APA (7th ed.) Citation

Cysique, L., Hewitt, T., Croitoru-Lamoury, J., Taddei, K., Martins, R., Chew, C., . . . Brew, B. (2015). APOE e4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals: A cross-sectional observational study. BioMed Central Ltd.

Chicago Style (17th ed.) Citation

Cysique, L., T. Hewitt, J. Croitoru-Lamoury, K. Taddei, R. Martins, C. Chew, N. Davies, Patricia Price, and B. Brew. APOE E4 Moderates Abnormal CSF-abeta-42 Levels, While Neurocognitive Impairment Is Associated with Abnormal CSF Tau Levels in HIV+ Individuals: A Cross-sectional Observational Study. BioMed Central Ltd, 2015.

MLA (9th ed.) Citation

Cysique, L., et al. APOE E4 Moderates Abnormal CSF-abeta-42 Levels, While Neurocognitive Impairment Is Associated with Abnormal CSF Tau Levels in HIV+ Individuals: A Cross-sectional Observational Study. BioMed Central Ltd, 2015.